Business Description
Novanta Inc
NAICS : 335999
SIC : 3379
ISIN : CA67000B1040
Description
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.69 | |||||
| Debt-to-EBITDA | 3.02 | |||||
| Interest Coverage | 3.85 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6.7 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.9 | |||||
| 3-Year EBITDA Growth Rate | 19.7 | |||||
| 3-Year EPS without NRI Growth Rate | 19.4 | |||||
| 3-Year FCF Growth Rate | -8 | |||||
| 3-Year Book Growth Rate | 11.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 23.87 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.78 | |||||
| 9-Day RSI | 39.38 | |||||
| 14-Day RSI | 42.86 | |||||
| 6-1 Month Momentum % | 11.64 | |||||
| 12-1 Month Momentum % | 24.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.79 | |||||
| Quick Ratio | 1.81 | |||||
| Cash Ratio | 0.59 | |||||
| Days Inventory | 110.82 | |||||
| Days Sales Outstanding | 58.77 | |||||
| Days Payable | 47.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | -0.81 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.42 | |||||
| Operating Margin % | 12.73 | |||||
| Net Margin % | 6.52 | |||||
| FCF Margin % | 12.47 | |||||
| ROE % | 8.73 | |||||
| ROA % | 4.52 | |||||
| ROIC % | 8.27 | |||||
| ROC (Joel Greenblatt) % | 34.67 | |||||
| ROCE % | 9.94 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 100.59 | |||||
| Forward PE Ratio | 45.99 | |||||
| PE Ratio without NRI | 67.58 | |||||
| Shiller PE Ratio | 115.54 | |||||
| Price-to-Owner-Earnings | 72.89 | |||||
| PEG Ratio | 7.11 | |||||
| PS Ratio | 6.53 | |||||
| PB Ratio | 8.08 | |||||
| Price-to-Free-Cash-Flow | 52.49 | |||||
| Price-to-Operating-Cash-Flow | 44.33 | |||||
| EV-to-EBIT | 54.64 | |||||
| EV-to-EBITDA | 37.71 | |||||
| EV-to-Revenue | 6.96 | |||||
| EV-to-FCF | 55.92 | |||||
| Price-to-Projected-FCF | 3.47 | |||||
| Price-to-DCF (Earnings Based) | 2.53 | |||||
| Price-to-DCF (FCF Based) | 3.14 | |||||
| Price-to-Median-PS-Value | 1.32 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5 | |||||
| Earnings Yield (Greenblatt) % | 1.83 | |||||
| FCF Yield % | 1.91 | |||||
| Forward Rate of Return (Yacktman) % | 15.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novanta Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 845.779 | ||
| EPS (TTM) (€) | 1.52 | ||
| Beta | 1.43 | ||
| Volatility % | 22.46 | ||
| 14-Day RSI | 42.86 | ||
| 14-Day ATR (€) | 3.06094 | ||
| 20-Day SMA (€) | 160 | ||
| 12-1 Month Momentum % | 24.43 | ||
| 52-Week Range (€) | 132 - 171 | ||
| Shares Outstanding (Mil) | 35.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Novanta Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Novanta Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Novanta Inc Frequently Asked Questions
What is Novanta Inc(STU:1GSN)'s stock price today?
The current price of STU:1GSN is €155.00. The 52 week high of STU:1GSN is €171.00 and 52 week low is €132.00.
When is next earnings date of Novanta Inc(STU:1GSN)?
The next earnings date of Novanta Inc(STU:1GSN) is 2025-02-28 Est..
Does Novanta Inc(STU:1GSN) pay dividends? If so, how much?
Novanta Inc(STU:1GSN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers